Stock screenerAll disclosures →
EDGAR →
ROIV
Conviction 100HealthcareScan · Thu, Jun 25, 2026ROIV$34.03+0.06%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 6.87M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price34.03
Change+0.06%
Gap+1.07%
Rel volume3.37×
Avg volume6.36M
Avg $ vol196.8M
SMA 2030.22
SMA 5029.46
SMA 20023.96
Price vs 50+15.49%
Price vs 200+42.04%
MA stackbullish
50/200 cross—
Supertrendup · 30.57
RSI (14)72
MACD hist0.46
MACD crossbull · 7d
Stoch %K / %D90 / 90
ADX (14)27
+DI / −DI36 / 9
RSI divergence—
MACD divergence—
ATR %+3.48%
ADR %3.41%
52w high34.03
52w low10.74
From 52w high+0.00%
Above 52w low+216.85%
New 52w highYes
SqueezeOff
Bollinger width21.98%
%B1.07
Donchian pos90.51%
Donchian high34.67
Donchian low27.93
AVWAP (52w high)34.19
vs AVWAP high-0.46%
AVWAP (52w low)21.69
vs AVWAP low+56.90%
OBV trendUp
Chaikin MF (20)-0.04
Today vs 20d3.37×
Avg vol (14d)6.87M
Avg vol (20d)6.36M
Avg $ vol (20d)196.8M
Market cap24.48B
RS 3m (vs SPY)+14.32%
RS 6m (vs SPY)+44.03%
RS line new highYes
Trend template8/8
Technical rank92.1
1 week+9.07%
1 month+14.71%
3 months+24.38%
6 months+50.04%
1 year+194.89%
YTD+55.18%
P/E-81.65
P/B5.41
P/S—
P/FCF-32.27
EPS-0.5400
Div yield—
ROE-6.62%
ROA-5.25%
Debt/Eq0.05
Current18.37
EV/EBITDA-45.49
Gross margin—
Net margin—
Rev growth-71.57%
EPS growth-74.30%
Price target36.72
Target upside7.90%
Analyst ratingBuy
Institutional80.47%
Ent. value23.28B
Revenue2M
Net income-265.89M
Gross profit—
Free cash flow-758.56M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out719.27M
Employees721
ListedFri, Oct 1, 2021
Free float371.02M
Float %51.8%
Short interest36.23M
Days to cover4.1d
Short volume48.0%
Squeeze score61 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.46 vs −$0.38
Last surprise-21.1% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank92.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance31.70
Support27.69
Days since event—
Candle confirm—
News sentiment—
Financials as of Wed, Dec 31, 2025 · quarterly.
Congress activity
Disclosed STOCK Act trades in ROIV · 3 recent
Insider activity
SEC Form 4 transactions in ROIV · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Venker Eric President & Immunovant CEO · Common Shares · 2026-05-22 | Sell | 200K | $6.1M | 2026-05-22 | 2026-05-22 |
Venker Eric President & Immunovant CEO · Stock Option (Right to Buy) · 2026-05-22 | Exercise | 200K | $0 | 2026-05-22 | 2026-05-22 |
Venker Eric President & Immunovant CEO · Common Shares · 2026-05-22 | Exercise | 200K | $770K | 2026-05-22 | 2026-05-22 |
Pulik Richard CFO · Common Shares · 2026-05-20 | Tax | 18.96K | $615K | 2026-05-20 | 2026-05-22 |
Venker Eric President & Immunovant CEO · Common Shares · 2026-05-20 | Tax | 34.48K | $1.1M | 2026-05-20 | 2026-05-22 |
Pulik Richard CFO · Common Shares · 2026-04-20 | Grant | 60.64K | $0 | 2026-04-20 | 2026-04-22 |
Humes Jennifer Chief Accounting Officer · Stock Option (Right to Buy) · 2026-04-20 | Grant | 27.16K | $0 | 2026-04-20 | 2026-04-22 |
Venker Eric President & Immunovant CEO · Stock Option (Right to Buy) · 2026-04-20 | Exercise | 200K | $0 | 2026-04-20 | 2026-04-22 |
Humes Jennifer Chief Accounting Officer · Common Shares · 2026-04-20 | Grant | 29.17K | $0 | 2026-04-20 | 2026-04-22 |
Venker Eric President & Immunovant CEO · Common Shares · 2026-04-20 | Exercise | 200K | $770K | 2026-04-20 | 2026-04-22 |
SEC filings
EDGAR filings in ROIV · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.